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Hypoxia-induced apoptosis in glomerular endothelial cells:
Involvement of mitochondrial pathways.
Background. Glomerular endothelial cells (GENs) play a key
role in the preservation and reconstruction of the glomerular
capillary network following injury, thus maintaining the tissue
oxygenation. Accumulating evidence has shown that failure to
maintain the microcirculation leads to irreversible glomerular
injury and glomerular sclerosis. In this regard, the behavior of
endothelial cells in a hypoxic milieu is of interest.
Methods. We exposed cultured GENs to hypoxia and
observed apoptosis by annexin V assay. We examined mito-
chondrial signaling, focusing on Bcl2 and Bax by real-time
polymerase chain reaction (PCR), immunocytochemistry, and
immunoprecipitaion. Furthermore, we examined the response
to hypoxia in an overexpression model of Bcl2.
Results. Hypoxic treatment induced apoptosis in 12.8% ±
1.1% of GENs at 24 hours, and in 19.8% ± 0.9% at 24 hours
followed by 8 hours of reoxygenation. The expression of Bcl2
mRNA decreased to 0.45- ± 0.15-fold at 24 hours, whereas that
of Bax increased to 7.3- ± 1.2-fold 1 hour after reoxygenation,
accompanied by translocation from the cytosol to mitochondria.
These changes were associated with a decrease in mitochondrial
membrane potentials and an increase in caspase-9 activity. Both
overexpression of Bcl2 and inhibition of Bax protected GENs
from hypoxic injury.
Conclusion. We conclude that changes of quantity and local-
ization of Bcl2 and Bax contribute to hypoxia-mediated apop-
tosis of GENs in vitro. Further investigation into glomerular
endothelial cell injury and intracellular signaling in a hypoxic
milieu is required to better understand and ultimately prevent
progression of chronic kidney disease.
The microcirculation of the kidney, glomerular or per-
itubular, contributes to the maintenance of normal renal
function and recovery from immune- or nonimmune-
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mediated glomerular injury. Glomerular endothelial cells
(GENs) are a major component in re-constructing the
capillary network following injury and their failure to do
so leads to compromised oxygen and nutrient delivery
to the surrounding tissues, activating various cytokines
such as transforming growth factor-b (TGF-b) [1] and
angiotensin II [2], adhesion molecules and coagulation
pathways. This eventually leads to glomerular sclerosis
[3]. Over the last decade, an array of evidence has demon-
strated that in reversible models of glomerular injury
the capillary repair follows the initial glomerular dam-
age, whereas in irreversible models it fails to ensue [4–6].
Apoptosis of the endothelial cells most likely plays a role
during the deterioration [6, 7] and recovery phase [8] of
the glomerular capillary network [9, 10]. However, the
changes of GENs in a hypoxic milieu remain only partly
defined.
Apoptosis is a programmed form of cell death, mor-
phologically characterized by cell shrinkage and conden-
sation of both nuclear chromatin and cytoplasm [11, 12].
On a molecular basis, two distinct signaling pathways are
known to be involved, the mitochondrial pathway and
the death receptor (Fas-Fas ligand) pathway.
Bcl2 is a major antiapoptotic protein residing in the
mitochondrial membrane [13], which is now widely rec-
ognized to protect cells against various forms of apoptotic
stimuli. Bax, on the other hand, is a proapoptotic factor,
which exerts its function by homodimerizing and accu-
mulating in the mitochondrial membrane [14, 15]. Bcl2
family proteins regulate mitochondrial membrane stabil-
ity. Disruption of the mitochondrial membrane leads to
cytochrome C release, activation of caspase-9, and even-
tually apoptotic cell death.
The death receptor, Fas (CD95), is a member of the
tumor necrosis factor (TNF) receptor family and when
Fas-ligand (FasL, CD95L) on an effecter cell binds to
Fas, it transduces its death signal through activation of
the downstream cysteine protease, caspase-8.
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In this study, we exposed cultured GENs to a hypoxic
milieu and observed apoptotic cell death, based on mor-
phologic and biochemical criteria. Further insights into
the death signaling have clarified an involvement of the
mitochondrial pathways.
METHODS
Cell culture and hypoxia
GENs were isolated and cloned as reported previously
[16]. In brief, glomeruli were isolated from male Sprague-
Dawley rats by sieving and cultured in hepatoma G2 con-
ditioned MDCB 107 medium and K1 medium at a 1:1
ratio. Outgrowth with the appearance of endothelial cells
was isolated, cloned, and characterized by immunostain-
ing. We observed positive staining with JG12 [17], while
staining with podocalyxin, nephrin, a-smooth muscle
actin (a-SMA), ED-1 was all negative. Clones were fur-
ther certified to be of endothelial origin from biochemical
aspects, such as uptake of dil-acetyl low-density lipopro-
tein (LDL) and possession of angiotensin-converting
enzyme (ACE) activity. Cells were cultured and main-
tained in RPMI 1640 (Nissui Seiyaku, Tokyo, Japan)
containing 2000 mg/L glucose, supplemented with 10%
fetal bovine serum (FBS) (JRH Biosciences, Lenexa, KS,
USA) and 10% NuSerum (BD Biosciences, Bedford,
MA, USA) at 37◦C under a humidified atmosphere of
5% CO2/95% air.
Hypoxic conditions were carried out using Anaerocult
A Mini (Merck, Darmstadt, Germany), which reduces the
oxygen content to 0.2% in an hour. GENs were subjected
to hypoxia upon reaching 80% confluence and were main-
tained in serum-free culture medium during the process.
After hypoxic stimulation, all samples were processed as
quickly as possible, usually within 6 minutes, to minimize
the effect of reoxygenation.
Detection of apoptosis
Quantification of apoptotic cells was carried out by
annexin V binding assays as described previously [18].
Briefly, hypoxia-treated cells in 60 mm culture plates
(Falcon, NJ, USA) were collected in a 15 mL cen-
trifuge tube (TPP, Transadingen, Switzerland). After
a wash in phosphate-buffered saline (PBS), cells
were double-stained with annexin V-fluorescein isoth-
iocyanate (FITC) and propidium iodide utilizing the
annexin V-FITC Apoptosis Detection Kit (Medical
and Biological Laboratories, Nagoya, Japan). Stained
cells were later processed by flow cytometry analysis
(FACScan and LYSIS II software; both from Beckton
Dickinson, Franklin Lakes, NJ, USA). At least 10,000
cells were assayed per condition. The fraction of cells that
were annexin V-positive and propidium iodide–negative
were considered apoptotic.
To further confirm the apoptotic changes in GENs,
propidium iodide–stained cells were visualized with a
microscope equipped with fluorescence filters (Olympus,
Tokyo, Japan) to observe nuclear changes such as bleb-
bing or chromatin condensation. Furthermore, terminal
deoxynucleotidyl transferase (TdT)-mediated deoxyuri-
dine triphosphate (dUTP) nick end labeling (TUNEL)
staining was performed in an attempt to detect internucle-
osomal DNA breakage. Control or hypoxia-treated cells
were collected and fixed in 4% paraformaldehyde for
20 minutes at room temperature, and then attached
to glass-slides. After treatment with proteinase
K (10 lg/mL, 37◦C, 15 min), samples were preincu-
bated in TdT buffer (140 mmol/L sodium cacodylate,
1 mmol/L cobalt chloride, 30 mmol/L Tris-HCl, pH 7.2)
for 5 minutes. TdT enzyme (Promega, Madison,WI,
USA) and Fluorescein-12-dUTP (Roche, Mannheim,
Germany) were added and incubated at 37◦C for 1 hour.
The reaction was stopped by rinsing the samples with
300 mmol/L NaCl containing 30 mmol/L sodium citrate.
For counter-staining, samples were subsequently stained
with propidium iodide.
Measurement of Bcl2 and Bax mRNA
The expression of Bcl2 and Bax mRNA was quanti-
fied by real-time polymerase chain reaction (PCR). Total
RNA of treated or untreated GENs was extracted using
Isogen (Nippon Gene, Tokyo, Japan) according to the
manufacturer’s instructions. Aliquots of 1 lg RNA were
reverse-transcribed at 42◦C for 1 hour using ImProm-
II Reverse Transcription System (Promega), and
1/20 (vol/vol) of cDNA was used as a template for real-
time PCR analysis. PCR reactions were performed on an
iCycler (Bio-Rad, Hercules, CA, USA) under the follow-
ing conditions: initial activation at 94◦C for 15 minutes,
40 cycles of amplification at 94◦C for 15 seconds, 55◦C for
30 seconds, and 72◦C for 30 seconds. QuantiTest CYBR
Green PCT Kit (Qiagen, Valencia, CA, USA) was used
as the reagent.
To measure the starting quantity of mRNA, the stan-
dard curve method was used for each reaction and cor-
rected for the amount of b-actin mRNA. The pairs of
primers used were Bcl2: forward 5′-CTGTGGATGAC
TGAGTACCTGAAC-3′, reverse 5′-AGAGACAGCCA
GGAGAAATCAAAC-3′; Bax: forward 5′-TCATGAA
GACAGGGGCCTTTT-3′, reverse 5′-CAATCATCCTC
TGCAGCTCCA-3′; and b-actin: forward 5′-CTTTCTA
CAATGAGCTGCGTG-3′, reverse 5′-TCATGAGGTA
GTCTGTCAGG-3′.
Immunocytochemistry
To further characterize the expression and localiza-
tion of Bcl2 and Bax inside the cells, we detected cor-
responding antigens with fluorescein-labeled antibodies.
GENs were seeded on 4-well Lab-Tek chamber slides
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(Nalge Nunc International, Rochester, IL, USA) and
cultured in hypoxic conditions. Samples were fixed with
4% paraformaldehyde in PBS at room temperature for
20 minutes and permeabilized with 0.2% Triton X-100
for 5 minutes. Cells were stained with anti-Bcl2 an-
tibody (mouse monoclonal, Santa Cruz Biochemistry,
Santa Cruz, CA, USA) at 1/50, which was detected by
Alexa Flour 546 antimouse IgG (Molecular Probes, Eu-
gene, OR, USA) at 1/100, or incubated with anti-Bax an-
tibody (rabbit polyclonal, Santa Cruz Biochemistry) at
1/100, followed by incubation with biotinylated antirabbit
IgG (Vector, Burlingame, CA, USA) at 1/400 and Ore-
gon Green 488 streptavidin (Molecular Probes) at 1/400
after inactivation of endogenous biotin (Avidin/Biotin
Blocking Kit) (Vector). For Bax-staining, double-staining
with MitoTracker (Molecular Probes) was performed to
demonstrate the translocation of Bax protein from the cy-
tosol to mitochondria. Negative controls included omis-
sion of the incubation step with the primary antibodies.
Immunoprecipitation and immunoblotting
The interaction between Bcl2 and Bax under normoxic
or hypoxic conditions was evaluated by immunoprecip-
itation. Briefly, cells were collected and lysed in 1%
Nonidet P (NP) 40 lysis buffer (150 mmol/L NaCl, 1%
NP-40, and 50 mmol/L Tris-HCl, pH 8.0) contain-
ing 1 mmol/L phenylmethylsulfonyl fluoride (PMSF).
Aliquots of protein samples were incubated with 1 lg of
anti-Bcl2 antibody or anti-Bax antibody at 4◦C for 1 hour.
Immunoprecipitates were captured with 25 lL of protein
G sepharose beads (Amersham, Piscataway, NJ, USA)
for another hour. The beads were spun down and washed
three times with the lysis buffer. Immune complexes
were eluted from the beads with 40 lL of sodium do-
decyl sulfate (SDS) sample buffer, boiled for 5 minutes,
and resolved by 12% SDS-polyacrylamide gel elec-
trophoresis (PAGE).
Immunoblot analysis was performed under reduc-
ing conditions. Separated samples were transferred to
polyvinylidine difluoride (PVDF) membranes (Millipore,
Tokyo, Japan). Membranes were blocked with 2.5%
skim milk and incubated with anti-Bcl2 antibody at
1/100 and alkaline phosphatase-conjugated antimouse
IgG (Promega) at 1/1000, or anti-Bax antibody at 1/200
and alkaline phosphatase-conjugated antirabbit IgG
(Promega) at 1/1000. 5-Bromo-4-chloro-3-indolyl phos-
phate/nitro blue tetrazolium (BCIP/NBT) tablets (Sigma
Chemical Co., St. Louis, MO, USA) were used as a sub-
strate. Coomassie Brilliant Blue (CBB) staining of the
membranes confirmed equal loading and transfer.
Measurement of mitochondrial membrane potentials
and caspase-9 activity
Changes in mitochondrial membrane potentials were
measured semiquantitatively by flow cytometry. Cells
treated as indicated were collected in 15 mL polystyrene
centrifuge tubes and incubated with 10 lmol/L rhoda-
mine-123 (Wako, Osaka, Japan) for 15 minutes.
After a wash in PBS, cells were analyzed by fluorescence-
activated cell sorter (FACS).
To measure the caspase-9 activity, a colorimetric
assay kit (MBL) was used. In brief, aliquots of 120 lg pro-
tein samples were incubated in reaction buffer containing
10 mmol/L dithiothreitol (DTT) at 37◦C for 1 hour. A
200 lmol/L q-nitroaniline (qNA)–conjugated Leu-Glu-
His-Asp (LEHD-qNA) was used as a substrate. By mea-
suring the optic absorbance at 405 nm with a microtiter
plate reader, the caspase-9 activity was calculated.
Construction of the Bcl2 overexpression vector
and stable transfectants
To ascertain the involvement and antiapoptotic
effect of Bcl2 in hypoxia-induced GEN apoptosis, we
constructed stable transfectants overexpressing rat Bcl2.
An open reading frame coding for the rat Bcl2 was ob-
tained from reverse transcription (RT)-PCR using total
RNA of Lewis rat kidney. Primers used here were forward
5′-gccaccATGGCGCAAGCCGGGAGAAC-3′ and re-
verse 5′-gctctagaTCACTTGTGGCCCAGGTATG-3′,
respectively. PCR reaction was performed at 95◦C for
30 seconds, 55◦C for 30 seconds, 72◦C for 45 seconds
for 35 cycles, followed by final extension at 72◦C for
7 minutes.
PCR fragments of 725nt were subcloned into pCR2.1
(Invitrogen, San Diego, CA, USA) and analyzed by
dideoxy-sequencing. The sequence-confirmed fragment
was digested with EcoR1 and ligated to the mammalian
expression vector, pcDNA3.1(−) (Invitrogen). The vec-
tor plasmid (pcDNA-Bcl2) was stably transfected into
GEN using Lipofectamine Reagent (Gibco Life Tech-
nologies, Rockville, MD, USA). Briefly, 2.0 × 105 GENs
were seeded in a 60 mm culture dish. Eighteen to 24 hours
later, the cells were washed with PBS and incubated in
serum-free culture medium containing 4 lg of the vector
plasmid and 8 lg of the cationic liposome for 9 hours.
Colonies of cells transfected with pcDNA-Bcl2 and con-
trol plasmid (pcDNA-control) were selected in the cul-
ture medium containing 1200 lg/mL geneticin (Sigma
Chemical Co.) and isolated utilizing cloning cylinders
(Iwaki Glass, Chiba, Japan). The stably transfected clones
were cultured and maintained in the culture medium con-
taining 600 lg/mL geneticin. The expression level of Bcl2
was analyzed by Western blotting.
Antisense experiments
We investigated the role for Bax by introducing anti-
sense oligonucleotides. GENs seeded on 96-well culture
plates (TPP) were transfected with either antisense
phosphorothioate oligonucleotide of Bax 5′-TGCTCCC
CGGACCCGTCCAT-3′ or corresponding sense
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Fig. 1. Hypoxia induces apoptosis in glomerular endothelial cells (GENs). (A) When we exposed GENs to 0.2% O2 for 24 hours (H24), 12.8% ±
1.1% of cells were categorized to apoptosis (P < 0.0001 vs. normoxic control, annexin V assay). In addition, 8 hours of reoxygenation following
hypoxia (H24R8) induced a more prominent number of apoptotic cells (19.8% ± 0.9%, P < 0.0001 vs. control). Prolonged hypoxia for up to
32 hours (H32) failed to induce an increase in the number of apoptotic cells (N = 3, annexin V assay). (B) The cell viability was checked by
promidium iodide staining. Exposure of GENs to 24 hours of hypoxia (H24) or hypoxia followed by 8 hours of reoxygenation (H24R8) resulted in
38.8% ± 8.3% and 47.5% ± 6.6% of surviving cells, respectively. Prolonged hypoxia up to 32 hours (H32) led to an equivalent number of viable
cells (33.8% ± 2.3%) (N = 3). (C) The representative data of the annexin V assay. The cluster of cells in the right lower quadrant was determined
apoptotic. FL1 denotes annexin V-fluorescein isothiocyanate (FITC); FL2 denotes promidium iodide (PI). ∗P < 0.05; ∗∗P < 0.01 vs. normoxic
control.
oligo-nucleotiede 5′-ATGGACGGGTCCGGGGAGCA-
3′ at 1 lmol/L using Lipofectamine Reagent [19]. Forty-
eight hours after transfection, GENs were subjected to
hypoxic stimulation as indicated. The cytoprotective
effect it conferred was measured by lactate dehydroge-
nase (LDH) release assay (Wako). By measuring the
optic absorbance of both supernatants and cell lysates at
560 nm, the percentage of LDH released outside the
cells was calculated.
Statistical analysis
Stat View version 5.0 (SAS Institute, Cary, NC, USA)
was used for statistical analysis. The data obtained
here were compared using unpaired Student t tests and
expressed as means ± SEM. P values of <0.05 were
considered statistically significant. For multiple com-
parisons, the data were adjusted with Bonferroni/Dunn
method.
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Fig. 2. Morphologic changes in the nucleus
and terminal deoxynucleotidyl transferase
(TdT)-mediated deoxyuridine triphosphate
(dUTP) nick end labeling (TUNEL) staining.
(A and B) In promidium iodide staining, a
proportion of nuclei presented with the ap-
pearance of nuclear blebbing and chromatin
condensation, consistent with the pathologic
changes in apoptosis (B), while in control cells,
the above changes were absent (A). (C and
D) Furthermore, TUNEL staining showed the
presence of nuclear breakage, a hallmark of
apoptosis, in hypoxia-treated cells (D, arrow-
heads), whereas there was no obvious staining
in control (C). Yellow staining indicates the
computer-assigned designation for the colo-
calization of red (nucleus) and green [fluores-
cein isothiocyanate (FITC)-labeled dUTP]. A
magnified view of TUNEL-positive cells is
shown in the lower left of (D).
RESULTS
Hypoxia with or without reoxygenation induces
apoptosis in cultured GENs
We tested the hypothesis that cultured GENs might
proceed to apoptosis under hypoxic conditions. As seen
in Figure 1A, 0.2% O2 for 24 hours (H24) resulted in
12.8% ± 1.1% of GENs becoming apoptotic (P < 0.0001
vs. normoxic control, annexin V assay). Of interest,
8 hours of reoxygenation following hypoxia (H24R8)
induced an increase in the number of apoptotic cells
(19.8% ± 0.9%, P < 0.0001 vs. control). Prolonged
hypoxia for up to 32 hours (H32) failed to exaggerate
induction of apoptosis. Representative data of the
annexin V assays are shown in Figure 1C.
We also checked cell viability, which includes both
apoptosis and necrosis, by propidium iodide staining.
Exposure of GENs to 24 hours of hypoxia (H24) alone or
followed by 8 hours of reoxygenation (H24R8) resulted
in 38.8% ± 8.3% and 47.5% ± 6.6% of surviving cells,
respectively. Prolongation of incubation under hypoxic
conditions up to 32 hours (H32) did not affect the num-
ber of viable cells (33.8% ± 2.3%) compared with that
after 24 hours of hypoxia (P = 0.56) (Fig. 1B).
Apoptotic changes were confirmed by nuclear stain-
ing and the TUNEL method. When we stained treated
H24R8 cells with promidium iodide, a proportion of
nuclei displayed nuclear blebbing and chromatin conden-
sation, consistent with the pathologic changes of apopto-
sis (Fig. 2B), while in control cells, the above changes were
absent (Fig. 2A). Furthermore, TUNEL staining showed
the presence of nuclear breakage, a hallmark of apop-
tosis, in hypoxia-treated cells (Fig. 2D). In contrast, few
positive stainings for TUNEL were detected in controls
(Fig. 2C).
Changes in mRNA expression of mitochondrial
pro- and antiapoptotic genes
In an attempt to gain some insights into death signal-
ing, we checked the changes in mRNA expression of Bcl2
and Bax by real-time quantitative PCR. Figure 3A and
B represents the temporal profiles of each gene. Twenty-
four hours of hypoxia (H24) reduced Bcl2 expression to
0.45 ± 0.15 fold of the control level, although the
difference did not reach statistical significance (P =
0.08). Subsequent reoxygenation of 1 to 4 hours did not
cause significant changes in Bcl2 mRNA expression. Of
interest, 8 hours of reoxygenation resulted in increased
expression of Bcl2 mRNA (2.0 ± 0.3 fold, P = 0.005
vs. control, discussed below). In contrast to Bcl2, Bax
expression reached its maximum 1 hour after reoxygena-
tion (H24R1) (7.3 ± 1.2 fold, P < 0.0001), and then
subsided gradually. With the above observations, we cal-
culated the Bax/Bcl2 ratio, commonly used as an indicator
of the death signal mediated by mitochondrial pathways.
As shown in Figure 3C, the ratio was 2.6- and 6.7-fold
at 24H and H24R1, respectively, returning to baseline
8 hours after reoxygenation.
A decrease in Bcl2 protein during hypoxia, an increase
and translocation of Bax after reoxygenation
We further observed the expression of Bcl2 and Bax
by immunocytochemistry. Bcl2 shows its signal in the
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Fig. 3. Changes in Bcl2 and Bax mRNA expression. Changes in mRNA
expression of Bcl2 and Bax were measured by real-time polymerase
chain reaction (PCR). (A and B) The temporal profile of Bcl2 and Bax,
respectively. Twenty-four hours of hypoxia (H24) reduced the Bcl2 ex-
pression to 0.45 ± 0.15 fold of the control level, (P = 0.08, not sig-
nificant). Subsequent reoxygenation of 8 hours (H24R8) resulted in
increased expression of Bcl2 mRNA (2.0 ± 0.3 fold, P = 0.005 vs. con-
trol). In contrast to Bcl2, Bax expression reached its maximum 1 hour
after reoxygenation (H24R1) (7.3 ± 1.2 fold, P < 0.0001), which sub-
sided gradually. (C) The Bax/Bcl2 ratio was 2.6- and 6.7-fold at H24,
H24R1, respectively, which returned to the baseline 8 hours after re-
oxygenation. (N = 4, real-time PCR). ∗∗P < 0.01 vs. normoxic control.
perinuclear area, indicating that Bcl2 is a protein
localized in mitochondria. The signal intensity decreased
mildly following hypoxic treatment (Fig. 4A and B). Bax,
on the other hand, was detected diffusely in the cytosol
in normoxic controls, whereas it increased 2 hours after
reoxygenation (H24R2). Importantly, the Bax protein
changed its staining pattern from a diffuse to a perin-
uclear localization in some cells, indicating the translo-
cation of Bax from the cytosol to mitochondria during
apoptosis (Fig. 4C and D). In Figure 4C and D, double-
staining was performed with MitoTracker to more clearly
demonstrate the translocation of Bax, upon hypoxic
stimulation. Negative controls included omission of the
incubation step with the primary antibody, in which no
positive staining was observed (not shown). In this study,
the morphologic changes of necrotic cells, such as shrink-
age and membrane disintegration, were not obvious in
hypoxia-treated samples, probably reflecting the fact that
dead GENs easily detach from the slides and are lost
during staining. In Figure 4E, a representative figure of
Western blotting is presented to show the relative
decrease in Bcl2 and increase in Bax upon hypoxic
stimulation.
To explore interactions between the translocated Bax
and mitochondrial Bcl2, we performed immunoprecipi-
tation to document the level of Bcl2-associated Bax.
Both in control and hypoxia-treated samples, anti-
Bcl2 antibody coprecipitated Bax protein. However, anti-
Bcl2 precipitated quantitatively similar amounts of Bax
in each condition. Immunoprecipitation with anti-Bax
antibody and subsequent immunoblotting with anti-Bcl2
antibody produced similar results (Fig. 5). Considering
the increased expression of Bax, it seems reasonable to
speculate that Bax does not form heterodimers with Bcl2
during hypoxia, upon translocation.
Mitochondrial membrane potentials and
caspase-9 activity
Changes in mitochondrial membrane potentials were
measured quantitatively by rhodamine-123 staining and
flow cytometry analysis. Both hypoxia alone (H24) and
hypoxia followed by reoxygenation (H24R2) caused a
significant decrease in rhodamine-123 uptake, as com-
pared to normoxic controls (Fig. 6A). In addition, we
measured the relative caspase-9 activity, a cysteine pro-
tease activated upon stimulation of the mitochondria-
mediated apoptotic death signal. As shown in Figure 6B,
24 hours of hypoxia (H24) caused a 440% ± 42%
increase of caspase-9 activity, whereas hypoxia followed
by 2 hours of reoxygenation (H24R2) resulted in a
543% ± 32% increase. Following reoxygenation, the
elevated caspase-9 activity persisted throughout the
observation period for up to 8 hours of reoxygena-
tion. Prolonged reoxygenation period for up to 16 hours
resulted in a more receded activity (220.5% ± 28.7%).
Bcl2 overexpression ameliorates hypoxia-associated
GEN injury
The above findings have shown that hypoxia, alone
or in combination with reoxygenation, causes GEN
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Bax
N H24
N H24R2
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apoptosis through the mitochondrial pathway. In this
regard, we hypothesized that overexpression of Bcl2,
an antiapoptotic gene, might ameliorate hypoxia-
associated cell injury. Figure 7A shows the expression lev-
els of Bcl2 and Bax in control and Bcl2-overexpressing
clones in normoxia. The sample of the stable transfec-
tants showed a significant increase in the amount of Bcl2
expression, which was detected as a strong band at 26 kD.
Fig. 4. A decrease in Bcl2 protein during hypoxia, an increase and
translocation of Bax after reoxygenation. The expression of Bcl2 and
Bax was also examined by immunocytochemistry and Western blot-
ting. Bcl2 staining is localized mainly in the perinuclear area, consistent
with the mitochondrial pattern. The signal intensity decreased mildly by
hypoxic treatment (A and B). Bax, on the other hand, was detected dif-
fusely in the cytosol in normoxia, whereas the signal intensity increased
2 hours after reoxygenation (H24R2). In some cells, the Bax protein
changed its staining pattern from diffuse to perinuclear localization, in-
dicating the translocalization of Bax from the cytosol to mitochondria
(C and D). For Bax-staining, double-staining was performed with Mito-
Tracker to visualize the translocation from the cytosol to mitochondria.
Western blotting was performed to compare the relative band intensity
of Bcl2 and Bax in normoxic and hypoxic conditions (E).
The relative amount of Bcl2 and Bax mRNA in con-
trol and Bcl2-overexpressing GENs was examined in
normoxia (N), simple hypoxia (H24), and 1 hour follow-
ing reoxygenation (H24R1). The amount of Bcl2 mRNA
was apparently higher in overexpression clones than in
control GENs at any condition tested. Interestingly, the
expression levels of Bax seemed to be inversely sup-
pressed in Bcl2-overexpressing clones as compared to
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Bax Bcl227 kD 27 kD
55 kD 55 kD
N  H24R2 N  H24R2
α BCL2 IP α Bax IP
Fig. 5. Immunoprecipitation of Bcl2 and Bax in normoxic and
hypoxic conditions. To investigate the interaction of Bcl2 and Bax upon
apoptotic stimulation, we checked the quantitative changes in Bcl2-
associated Bax and vice versa by immunoprecipitation (IP). Both in
control and hypoxia-treated samples, anti-Bcl2 antibody precipitated a
fraction of Bax protein. However, anti-Bcl2 did not precipitate a quan-
titatively different amount of Bax. Furthermore, immunoprecipitation
with anti-Bax antibody and subsequent immunoblotting with anti-Bcl2
antibody revealed the same result. These finding suggest that Bax does
not form further heterodimers with Bcl2 during hypoxia, upon translo-
cation. Two distinct bands at 55 and 27 kD represent IgG heavy and
light chains, respectively.
control GENs when they underwent hypoxic stimulation.
[0.81 ± 0.09fold vs. 1.17 ± 0.35fold at H24 (P = 0.1436),
1.86 ± 0.43fold vs. 7.27 ± 1.25fold at H24R1 (P =
0.0175)].
With the overexpression model, we checked the anti-
apoptotic effect of Bcl2 by annexin V assay. As shown
in Figure 7C, stable clones with Bcl2 clearly demon-
strated an antiapoptotic effect both in simple hypoxia
(H24) (5.9% ± 1.7% vs. 12.8% ± 1.1% in control, P =
0.03) and hypoxia followed by reoxygenation (H24R8)
(6.4% ± 3.5% vs. 19.8% ± 0.9%, P = 0.02). Figure 7D
represents the cytoprotective role for Bcl2, as measured
by propidium iodide staining. In both H24 and H24R8
groups, stable transfectants exhibited a cytoprotective ef-
fect over control clones. The proportion of surviving cells
was 67.4% ± 5.9% as compared to 38.8% ± 8.3% in con-
trol (P = 0.049) at H24, and 88.7% ± 3.2% vs. 47.5% ±
6.6% (P = 0.005) at H24R8, respectively.
Figure 7E shows changes in caspase-9 activity. Rela-
tive caspase-9 activity was markedly reduced to 246% ±
36% at H24 (vs. 440% ± 42% in control, P = 0.0246)
and 224% ± 29% at H24R2 (vs. 543% ± 32%, P =
0.002), respectively. Furthermore, the background dif-
ference of caspase-9 activity between control and
Bcl2-overexpression clones was negligible in normoxia.
During the course of our experiments, we obtained
five independent clones carrying the Bcl2-overexpression
vector and analyzed two in detail, both of which behaved
in the same manner against various degrees of hypoxic
stimulation.
Antisense treatment of Bax contributes to improvement
in hypoxia-mediated GEN injury
For the purpose of looking into the role Bax plays
in hypoxia-induced GEN injury, we performed a loss-
of-function study by using antisense oligonucleotide tar-
geted against the mRNA sequence 1-20 of rat Bax [19].
Treatment of GENs with 1 lmol/L antisense oligonu-
cleotide resulted in marked suppression of Bax mRNA
at 48 hours after delivery (Fig. 8A). When we measured
the cell damage by LDH assay, the percentage of LDH
released outside the cells was significantly reduced in the
antisense oligonucleotide group, both at H24 (14.8% ±
2.5% vs. 25.1% ± 1.7% in control, P = 0.0052) and H24R8
(10.5% ± 0.9% vs. 19.3% ± 2.1%, P < 0.0001) (Fig. 8B).
These findings have led us to conclude that the inhibi-
tion of Bax is equally important in ameliorating hypoxia-
induced GEN injury. It is also worth mentioning that
the toxic effect of the sense (control) oligonucleotide
was minimal at any time point we adopted. The appar-
ent dissociation in the percentage of dead cells from the
results by propidium iodide staining (Figs. 1B and 7C)
most probably arises from the difference in the sensi-
tivity of each methodology we used. We avoided using
propidium iodide staining in antisense experiments since
oligonucleotide delivery by cationic liposomes alone
affected the membrane permeability of propidum iodide
(not shown). Given these limitations, our findings clearly
indicate the significance of Bax in hypoxia-mediated
GEN injury.
DISCUSSION
In this study, we demonstrated that hypoxia, alone or
in combination with reoxygenation, induces apoptotic
cell death in cultured GENs. We have also shown that
during the course of apoptosis, obvious changes in the
expression of Bcl2 and Bax mRNA occur. A decrease in
Bcl2 mRNA during simple hypoxia and an increase in
Bax mRNA 1 hour after reoxygenation were the most
notable quantitative changes during the observation per-
riod. The above changes were also demonstrated at the
protein level by immunocytochemistry and Western blot-
ting, in which Bcl2 staining turned faint during simple
hypoxia, while that of Bax became stronger in some
viable cells and translocated from the cytosol to mito-
chondria in others. Although they seemed to colocalize in
mitochondria upon hypoxic stimulation, immunoprecip-
itation failed to demonstrate an increased amount of
Bcl2-Bax heterodimers, similar to the results of Saikumar
et al [20]. Furthermore, a decrease in mitochondrial mem-
brane potentials and activation of caspase-9, a cysteine
protease located just downstream, ensued, all of which
are consistent with the current understanding of apop-
totic cell death mediated by the mitochondrial pathway.
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Fig. 6. Mitochondrial membrane potentials
and Caspase-9 activity. Changes in mitochon-
drial membrane potentials were measured
quantitatively by rhodamine-123 staining and
flow cytometry. In both treatment groups of
24 hours (H24) and 2 hours of reoxygena-
tion (H24R2), a decrease in rhodamine-123
uptake was observed, as compared to nor-
moxic control (A). A merged view is also
shown. The relative caspase-9 activity was
measured (B). Twenty-four hours of hypoxia
caused 440% ± 42% of caspase-9 activity,
whereas hypoxia followed by 2 hours of reoxy-
genation resulted in 543% ± 32%, which was
most prominent during the course. Following
reoxygenation, the elevated caspase-9 activity
persisted throughout the observation period
for up to 8 hours (N = 3). ∗P < 0.05; ∗∗P <
0.01 vs. normoxic control.
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When we consider cell injury induced by hypoxia,
the controversy arises not infrequently whether the low
oxygen content per se induces cellular injury or reoxy-
genation following hypoxia contributes to the cell dam-
age, and if so, to what degree each of the two distinct
mechanisms are involved. In our study utilizing GENs,
both of them led to changes in Bcl2 and Bax mRNA
expression levels and contributed to apoptotic cell death.
The rise in Bax mRNA 1 hour after reoxygenation was
the most striking phenomenon during the course, which
resulted in a marked increase in Bax/Bcl2 ratio. During
the reoxygenation period, the Bax/Bcl2 ratio returned
to the baseline 8 hours after reoxygenation. Although
Bax mRNA still remained 1.5 ± 0.3 fold increased com-
pared to the control level at that time, Bcl2, an antiapop-
totic gene, was also proportionally increased (2.0 ± 0.3
fold vs. control), suggesting an adaptation to minimize
the effects of hypoxia. A similar phenomenon was also
reported by Misao et al [21], in which they studied
autopsied specimens of hearts and detected enhanced
Bcl2 protein in salvaged myocytes at the site of infarction.
Although the downward caspase-9 activity still remained
elevated at the end of the observation period, further
examination at a later time course revealed its gradual
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Fig. 7. Bcl2 overexpression ameliorates
hypoxia-associated cell injury. (A) The
expression levels of Bcl2 and Bax in control
and Bcl2-overexpressing clones. Stable
transfectants exhibited an obviously stronger
band at 26 kD (Bcl2) than control glomerular
endothelial cells (GENs), while the ex-
pression level of Bax remained unaffected
in normoxia. (B) The relative amount of
Bcl2 and Bax mRNA in control and Bcl2-
overexpressing GENs at various conditions.
The amount of Bcl2 mRNA was significantly
higher in overexpression clones than control
GENs at any time point examined, while
that of Bax seemed to be suppressed by Blc2
overexpression under hypoxic conditions
[0.81 ± 0.09 fold vs. 1.17 ± 0.35 fold at
24 hours (H24) (P = 0.1436), 1.86 ± 0.43 fold
vs. 7.27 ± 1.25 fold at 1 hour of reoxygenation
(H24R1) (P = 0.0175)] [N = 3, real-time
polymerase chain reaction (PCR)]. ∗P <
0.05; ∗∗P < 0.01 vs. control GENs. (C) With
this model, we checked the antiapoptotic
effect of Bcl2 by annexin V assay. Stable
clones with Bcl2 clearly demonstrated an
anti-apoptotic effect both in simple hypoxia
(H24) (5.9% ± 1.7% vs. 12.8% ± 1.1% in
control, P = 0.0271) and hypoxia followed by
8 hours of reoxygenation (H24R8) (6.4% ±
3.5% vs. 19.8% ± 0.9%, P = 0.02). (D) The
cytoprotective role for Bcl2 is measured by
propidium iodide staining. In both H24 and
H24R8 groups, stable transfectants exhibited
a consistent cytoprotective effect over control
GENs. The proportion of surviving cells
was 67.4% ± 5.9% (vs. 38.8% ± 8.3% in
control GENs, P = 0.0485) at H24, 88.7% ±
3.2% (vs. 47.5% ± 6.6%, P = 0.0054) at
H24R8, respectively (N = 3). ∗P < 0.05; ∗∗P <
0.01 vs. control GENs. (E) Changes in
caspase-9 activity. Relative caspase-9 activity
was markedly reduced to 246% ± 36% at
H24 (vs. 440% ± 42% in control, P = 0.0246)
and 224% ± 29% at H24R2 (vs. 543% ±
32%, P = 0.0018), respectively. There was no
background difference between control and
Bcl2 overexpression clones (N = 3).
decrease. Taken together, it seems a reasonable spec-
ulation that the normalized Bax/Bcl2 ratio was the
initial termination process in the apoptotic death signal-
ing. It is also important to point out the possibility that
the persisting caspase-9 activity either reflects the slow
inactivation of caspase-9 itself or suggests the importance
of some antiapoptotic substance working downstream of
caspase-9, such as inhibitors of apoptosis (IAPs) or heat
shock proteins (HSPs), in hypoxia-induced apoptosis
[22–24].
The significance of reoxygenation during the apoptotic
process [25] suggests the possible involvement of reac-
tive oxygen species (ROS). In support of this view, our
preliminary experiments have shown that the stimula-
tion of GENs with hydrogen peroxide for 1 hour (50 to
800 lmol) induces a dose-dependent increase in Bax
mRNA, reaching 2.9 fold at 800 lmol.
In fact, mitochondria are the major source of
superoxide anion production in cells [26] and the imbal-
ance between production and inactivation of ROS may
determine the cell fate under oxidative stress. Therefore,
there is a possibility that administration of antioxidants,
such as a-tocophenol (vitamin E) and allopurinol, may
protect GENs against hypoxic injury, although a caution
is required in its interpretation because of the potential
problem in in vitro drug delivery [27].
Currently, it is generally accepted that hypoxia stabi-
lizes p53 [28] and results in apoptosis through activa-
tion of Bax [29–31] or other mechanisms [32], although
there are some controversies whether p53 is required in
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the production of apoptosis in cardiac myocytes [33, 34].
There is also evidence of a direct association between p53
and hypoxia-inducible factor 1a (HIF-1a) [35] and that
HIF-1a increases p53 levels [36]. In our experimental
settings, however, we have not tested so far whether
the increased Bax mRNA is associated with HIF-1a and
p53.
Besides the mitochondrial pathway we have discussed
here, there is another widely recognized apoptotic sig-
naling pathway, the death receptor (Fas-FasL) path-
way. Throughout the course of our experiments, we
have mainly focused on mitochondria-centered intracel-
lular signaling, which leaves the possibility of involve-
ment of the death receptor pathways in hypoxia-induced
endothelial cell death open.
CONCLUSION
We have shown that hypoxia, alone or in combination
with reoxygenation, induces a significant proportion of
apoptosis in cultured GENs. The intracellular signaling
was characterized by a decrease in Bcl2 during hypoxia
alone, and a marked increase and translocation of Bax
immediately after reoxygenation followed by a decrease
in mitochondrial membrane potentials and activation of
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Fig. 8. Effects of Bax antisense treatment on hypoxia-induced
glomerular endothelial cell (GEN) death. To address the role of Bax, we
treated GENs with antisense oligonucleotide (ODN). (A) The band of
Bax is obviously weaker in the antisense oligonucleotide-treated group,
as compared to control and sense oligonucleotide groups, indicating the
effective suppression of Bax by this method [semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR), 26 cycles]. (B) The
percentage of lactate dehydrogenase (LDH) released outside the cells.
An obvious decrease in LDH release was observed in the antisense
oligonucleotide group, both at 24 hours (H24) and after 8 hours of
reoxygenation (H24R8), as compared with control and sense oligonu-
cleotid groups. These findings clearly demonstrate the significance of
Bax in hypoxia-mediated GEN injury (LDH release assay, representa-
tive data are shown out of three independent experiments) (N = 8).
∗P < 0.05; ∗∗P < 0.01.
caspase-9. Our results strongly suggest an involvement
of the mitochondrial pathway during apoptosis. The role
of endothelial apoptosis in an in vivo hypoxic milieu
applies not only in immune- or nonimmune-mediated
glomerulopathies, but extends to thrombotic microan-
giopathies [37] and transplanted kidneys. Injured GENs
in a hypoxic environment, alone or in concert with
recruited leukocytes, cytokines and growth factors,
contribute to failure to preserve or reconstruct the
glomerular capillary network, which ultimately leads to
glomerular sclerosis. Further investigations on the apop-
totic mechanisms within the Bcl2-Bax axis will give a clue
to novel therapeutic implications.
NOTE ADDED IN PROOF
After this manuscript was submitted for publication,
we analyzed apoptotic pathways of proximal tubules
and observed involvement of mitochondrial pathways
[Biochem Biophys Res Comm (in press)].
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